About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Arbitration Award Issued

November 12, 2018

Click here to read more

Post navigation

Receipt of R&D Tax Incentive

Receipt of R&D Tax Incentive

Related Posts

Dosing Commences for CBD Topical Osteoarthritis Study

March 1, 2022March 2, 2022

Phosphagenics Market Update

September 1, 2017

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

October 7, 2014

Recent Posts

MEDIA | Hand it to cannabis
May 5, 2022
Quarterly Activities Report and 4C to 31 March 2022
April 29, 2022
Positive Results for Phase II Topical CBD Osteoarthritis Study
March 29, 2022

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.